Description: Aurora Cannabis Inc. produces and distributes medical cannabis products in Canada and internationally. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. It has a strategic agreement with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; and Alcanna, Radient Technologies, Micron Waste, Wagner Dimas, Evio, and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Home Page: www.auroramj.com
ACB Technical Analysis
500 - 10355 Jasper Avenue
Edmonton,
AB
T5J 1Y6
Canada
Phone:
855 279 4652
Officers
| Name | Title |
|---|---|
| Mr. Miguel Martin | CEO & Director |
| Mr. Glen Ibbott | Chief Financial Officer |
| Mr. Alex Miller | Exec. VP of Operations & Supply Chain |
| Ms. Lori Schick | Exec. VP of HR |
| Mr. Andre Jerome | Exec. VP of Global Bus. Devel. |
| Ananth Krishnan | VP of Capital Markets & Investor Relations |
| Mr. Nathalie Clark | Exec. VP, Gen. Counsel & Corp. Sec. |
| Michelle Lefler | VP of Communications & PR |
| Mr. Carey Squires | Exec. VP of Corp. Devel. & Strategy |
| Mr. John Barnet | Chief Cultivator |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.874 |
| Price-to-Sales TTM: | 1.6025 |
| IPO Date: | 2014-07-11 |
| Fiscal Year End: | June |
| Full Time Employees: | 1338 |